Public Sector Pension Investment Board Raises Position in HCA Healthcare, Inc. (NYSE:HCA)

Public Sector Pension Investment Board boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 67.8% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,829 shares of the company’s stock after acquiring an additional 2,760 shares during the quarter. Public Sector Pension Investment Board’s holdings in HCA Healthcare were worth $2,194,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Bangor Savings Bank boosted its position in HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares in the last quarter. MFA Wealth Advisors LLC acquired a new stake in HCA Healthcare in the second quarter worth about $27,000. Unique Wealth Strategies LLC purchased a new position in shares of HCA Healthcare in the 2nd quarter valued at approximately $28,000. GPS Wealth Strategies Group LLC boosted its stake in HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares in the last quarter. Finally, LifeSteps Financial Inc. acquired a new stake in shares of HCA Healthcare during the first quarter worth $33,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 0.1 %

HCA opened at $403.28 on Monday. The business has a fifty day simple moving average of $378.91 and a 200-day simple moving average of $343.05. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $409.42. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The firm has a market cap of $105.62 billion, a P/E ratio of 20.10, a P/E/G ratio of 1.52 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping the consensus estimate of $4.97 by $0.53. The firm had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same period in the prior year, the firm earned $4.29 EPS. On average, equities analysts expect that HCA Healthcare, Inc. will post 22.46 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be paid a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.65%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s payout ratio is 13.16%.

Insiders Place Their Bets

In related news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now owns 17,755 shares in the company, valued at approximately $6,303,912.75. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 17,202 shares of company stock valued at $6,407,273. 1.60% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

HCA has been the topic of several research reports. UBS Group increased their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Royal Bank of Canada upped their target price on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. StockNews.com raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Oppenheimer increased their price target on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Finally, Morgan Stanley began coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target on the stock. Five analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $359.89.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.